Cutaneous T-Cell Lymphoma Recurrent Recruiting Phase 2 Trials for Mycophenolate mofetil (DB00688)

Also known as: T-Cell Lymphoma Relapsed / Recurrent T-Cell Lymphoma / Recurrent Cutaneous T-cell lymphoma / T-cell lymphoma recurrent / Relapsed T-Cell Lymphoma / T-cell lymphoma NOS recurrent

IndicationStatusPhase
DBCOND0136063 (Cutaneous T-Cell Lymphoma Recurrent)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05805605Allo HSCT Using RIC and PTCy for Hematological DiseasesTreatment